Leishmania major aquaglyceroporin (LmjAQP1) adventitiously facilitates the uptake of antimonite [Sb(III)], an active form of Pentostam\uae or Glucantime\uae, which are the first line of defence against all forms of leishmaniasis. The present paper shows that LmjAQP1 activity is modulated by the mitogen-activated protein kinase, LmjMPK2. Leishmania parasites coexpressing LmjAQP1 and LmjMPK2 show increased Sb(III) uptake and increased Sb(III) sensitivity. When subjected to a hypo-osmotic stress, these cells show faster volume recovery than cells expressing LmjAQP1 alone. LmjAQP1 is phosphorylated in vivo at Thr-197 and this phosphorylation requires LmjMPK2 activity. Lys-42 of LmjMPK2 is critical for its kinase activity. Cells expressing alter...
The essential mitogen-activated protein kinase (MAP kinase), LmxMPK4, of Leishmania mexicana is mini...
The superfamily of protein kinases are emerging as valid therapeutic targets for anti-leishmanial dr...
Miltefosine (hexadecylphosphocholine, MLF) is the first oral drug with recognized efficacy against b...
Leishmaniasis is a protozoan parasitic disease that affects 12 million people worldwide. The first l...
Pentavalent antimonials [Sb(V)] are the primary drug of choice against all forms of leishmaniasis. E...
The disease, Leishmaniasis, is caused by the protozoal parasite Leishmania, which is transmitted by ...
International audienceDuring the infectious cycle, protozoan parasites of the genus Leishmania under...
International audienceDuring the infectious cycle, protozoan parasites undergo various developmental...
The parasitic protozoon Leishmania mexicana undergoes two major developmental stages in its life cyc...
Leishmaniasis is a life threatening tropical disease caused by Leishmania parasites that are transmi...
Pentavalent antimonial compounds have been the first line therapy for leishmaniasis; unfortunately t...
Leishmania is a digenetic protozoan parasite causing leishmaniasis in humans. The different clinical...
Background: Leishmania parasites undergo profound morphological and biochemical changes while passin...
AbstractATP-binding cassette (ABC) transporters have been associated with drug resistance in various...
A striking difference of the life stages of the protozoan parasite Leishmania is a long flagellum in...
The essential mitogen-activated protein kinase (MAP kinase), LmxMPK4, of Leishmania mexicana is mini...
The superfamily of protein kinases are emerging as valid therapeutic targets for anti-leishmanial dr...
Miltefosine (hexadecylphosphocholine, MLF) is the first oral drug with recognized efficacy against b...
Leishmaniasis is a protozoan parasitic disease that affects 12 million people worldwide. The first l...
Pentavalent antimonials [Sb(V)] are the primary drug of choice against all forms of leishmaniasis. E...
The disease, Leishmaniasis, is caused by the protozoal parasite Leishmania, which is transmitted by ...
International audienceDuring the infectious cycle, protozoan parasites of the genus Leishmania under...
International audienceDuring the infectious cycle, protozoan parasites undergo various developmental...
The parasitic protozoon Leishmania mexicana undergoes two major developmental stages in its life cyc...
Leishmaniasis is a life threatening tropical disease caused by Leishmania parasites that are transmi...
Pentavalent antimonial compounds have been the first line therapy for leishmaniasis; unfortunately t...
Leishmania is a digenetic protozoan parasite causing leishmaniasis in humans. The different clinical...
Background: Leishmania parasites undergo profound morphological and biochemical changes while passin...
AbstractATP-binding cassette (ABC) transporters have been associated with drug resistance in various...
A striking difference of the life stages of the protozoan parasite Leishmania is a long flagellum in...
The essential mitogen-activated protein kinase (MAP kinase), LmxMPK4, of Leishmania mexicana is mini...
The superfamily of protein kinases are emerging as valid therapeutic targets for anti-leishmanial dr...
Miltefosine (hexadecylphosphocholine, MLF) is the first oral drug with recognized efficacy against b...